Impact of immunosuppressive treatment and type of SARS-CoV-2 vaccine on antibody levels after three vaccinations in patients with chronic kidney disease or kidney replacement therapy.

Pim BouwmansA Lianne MesschendorpCéline ImhofJan-Stephan F SandersLuuk B HilbrandsMarlies E J ReindersPriya VartFrederike J BemelmanAlferso C AbrahamsRené M A van den DorpelMarc A G J Ten DamAiko P J de VriesTheo RispensMaurice SteenhuisRon T GansevoortMarc H Hemmeldernull null

Published in: Clinical kidney journal (2022)

Immunosuppressive treatment adversely affects the antibody levels after SARS-CoV-2 vaccination in patients with CKD G4/5, dialysis patients and KTR. mRNA-1273 vaccine induces a higher antibody level and higher frequency of adverse events.

Keyphrases

sars cov
replacement therapy
end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
respiratory syndrome coronavirus
smoking cessation
prognostic factors
combination therapy
patient reported outcomes
coronavirus disease